Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025
Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.
Explore Related Insights
- Double gain for UPS subscribers: Gratuity bonanza over and above lump-sum benefit for these government employees, here’s how
- Budget 2024: FM's speech sparks praise for employment scheme, angel tax cut
- Want to fly high in the drone industry? Check out these in-demand roles and skills
- Electric Motorcycle Gaining Traction Now
